WT1 and breast cancer: Similarly, in breast cancer, WT1-positive tumors were found to be more mesenchymal, and overexpression of WT1 in breast epithelial cells, HBL100, led to upregulation of mesenchymal markers, such as Vimentin (Vim) and Tenascin C (Tnc) [52].